Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Plitidepsin in
Combination with Sorafenib or Gemcitabine in Patients with Advanced Solid Tumors or Lymphomas
to determine the maximum tolerated dose (MTD) and the recommended dose (RD) of plitidepsin in
combination with sorafenib or gemcitabine in patients with advanced solid tumors or
lymphomas.